The Ministry of Food and Drug Safety (MFDS) said it granted orphan drug and developmental orphan drug designations to two ...

BOSTON, Mass. -- By Lee Han-soo / Korea Biomedical Review correspondent -- Korea’s biotechnology sector is at a strategic ...

Korean physicians recently pointed out that, to institutionalize the limited-time permitted telemedicine care, platforms ...

BOSTON, Mass. -- By Lee Han-soo / Korea Biomedical Review correspondent -- More than 80 Korean pharmaceutical, biotech, and ...

Samsung Bioepis and its European partner Biogen have been dealt a legal blow in Germany after a higher court ruled that ...

Celltrion has picked up additional approvals from the FDA and Health Canada for its biosimilar to Janssen’s Stelara, Steqeyma ...

Korea-based CDMO Binex has secured a fresh manufacturing deal with Celltrion to produce drug substances for two clinical-stage biosimilar candidates, the company said Monday.Under the contract, Binex ...

A mobile game-based digital therapy has been shown to help improve social skills in adolescents with autism spectrum disorder ...

Takeda Korea has launched Fruzaqla (fruquintinib), a once-daily oral treatment for metastatic colorectal cancer (mCRC), ...

Patients with urothelial carcinoma are increasingly abandoning treatment. New drugs are being developed, but health insurance ...

Yuhan Corp. is making an early case for its allergy biologic YH35324 in chronic spontaneous urticaria (CSU), the medical term ...

“Korean patients in the ASCENT-04 trial were happy to be in the trial, even if assigned to the placebo arm.”A breast cancer specialist I met last week at the American Society of Clinical Oncology Annu ...